HEADER RECEPTOR 09-JUL-09 2WNJ TITLE CRYSTAL STRUCTURE OF APLYSIA ACHBP IN COMPLEX WITH DMXBA COMPND MOL_ID: 1; COMPND 2 MOLECULE: SOLUBLE ACETYLCHOLINE RECEPTOR; COMPND 3 CHAIN: A, B, C, D, E; COMPND 4 FRAGMENT: RESIDUES 18-236; COMPND 5 SYNONYM: ACETYLCHOLINE BINDING PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: APLYSIA CALIFORNICA; SOURCE 3 ORGANISM_COMMON: CALIFORNIA SEA HARE; SOURCE 4 ORGANISM_TAXID: 6500; SOURCE 5 CELL: SENSORY CELL; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS RECEPTOR, ACETYLCHOLINE BINDING PROTEIN, DMXBA EXPDTA X-RAY DIFFRACTION AUTHOR G.SULZENBACHER,R.HIBBS,J.SHI,T.TALLEY,S.CONROD,W.KEM,P.TAYLOR, AUTHOR 2 P.MARCHOT,Y.BOURNE REVDAT 6 13-DEC-23 2WNJ 1 HETSYN LINK REVDAT 5 29-JUL-20 2WNJ 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 03-APR-19 2WNJ 1 SOURCE LINK REVDAT 3 13-JUL-11 2WNJ 1 VERSN REVDAT 2 03-NOV-09 2WNJ 1 JRNL REVDAT 1 01-SEP-09 2WNJ 0 JRNL AUTH R.E.HIBBS,G.SULZENBACHER,J.SHI,T.T.TALLEY,S.CONROD,W.R.KEM, JRNL AUTH 2 P.TAYLOR,P.MARCHOT,Y.BOURNE JRNL TITL STRUCTURAL DETERMINANTS FOR INTERACTION OF PARTIAL AGONISTS JRNL TITL 2 WITH ACETYLCHOLINE BINDING PROTEIN AND NEURONAL ALPHA7 JRNL TITL 3 NICOTINIC ACETYLCHOLINE RECEPTOR. JRNL REF EMBO J. V. 28 3040 2009 JRNL REFN ISSN 0261-4189 JRNL PMID 19696737 JRNL DOI 10.1038/EMBOJ.2009.227 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 116030 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 6066 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 8436 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.88 REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE SET COUNT : 423 REMARK 3 BIN FREE R VALUE : 0.2730 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8486 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 179 REMARK 3 SOLVENT ATOMS : 992 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 23.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.42000 REMARK 3 B22 (A**2) : -0.76000 REMARK 3 B33 (A**2) : 0.35000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.112 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.111 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.078 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.749 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9336 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 6274 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12788 ; 1.507 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): 15297 ; 0.903 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1154 ; 6.322 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 444 ;35.778 ;24.189 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1529 ;14.492 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 61 ;19.998 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1401 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 10388 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1943 ; 0.006 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1736 ; 0.201 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 6815 ; 0.220 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4541 ; 0.184 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 5101 ; 0.099 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 846 ; 0.183 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 14 ; 0.120 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 49 ; 0.283 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 23 ; 0.239 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5628 ; 1.051 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2157 ; 0.258 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 9019 ; 1.593 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4285 ; 2.294 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3722 ; 3.366 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 208 REMARK 3 ORIGIN FOR THE GROUP (A): 24.9023 11.1697 59.4215 REMARK 3 T TENSOR REMARK 3 T11: -0.1749 T22: -0.1670 REMARK 3 T33: -0.1218 T12: -0.0224 REMARK 3 T13: 0.0229 T23: -0.0018 REMARK 3 L TENSOR REMARK 3 L11: 1.0365 L22: 1.0994 REMARK 3 L33: 2.0370 L12: -0.0955 REMARK 3 L13: -0.0563 L23: -0.2111 REMARK 3 S TENSOR REMARK 3 S11: 0.0103 S12: 0.1111 S13: 0.1301 REMARK 3 S21: -0.0954 S22: -0.0496 S23: -0.2307 REMARK 3 S31: -0.0184 S32: 0.2032 S33: 0.0393 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B -3 B 207 REMARK 3 ORIGIN FOR THE GROUP (A): 0.6559 22.8550 60.4957 REMARK 3 T TENSOR REMARK 3 T11: -0.1293 T22: -0.2048 REMARK 3 T33: -0.0626 T12: 0.0223 REMARK 3 T13: 0.0067 T23: -0.0309 REMARK 3 L TENSOR REMARK 3 L11: 1.5387 L22: 1.2851 REMARK 3 L33: 1.6406 L12: 0.1631 REMARK 3 L13: 0.3795 L23: -0.1402 REMARK 3 S TENSOR REMARK 3 S11: 0.0116 S12: 0.1221 S13: 0.2039 REMARK 3 S21: -0.0990 S22: -0.0295 S23: 0.2281 REMARK 3 S31: -0.1618 S32: -0.0297 S33: 0.0178 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C -5 C 207 REMARK 3 ORIGIN FOR THE GROUP (A): -17.2688 3.5398 65.5964 REMARK 3 T TENSOR REMARK 3 T11: -0.1859 T22: -0.1347 REMARK 3 T33: -0.0761 T12: -0.0059 REMARK 3 T13: 0.0266 T23: -0.0271 REMARK 3 L TENSOR REMARK 3 L11: 0.8891 L22: 1.6520 REMARK 3 L33: 0.9857 L12: -0.0083 REMARK 3 L13: 0.0524 L23: 0.0452 REMARK 3 S TENSOR REMARK 3 S11: -0.0163 S12: 0.0338 S13: -0.0011 REMARK 3 S21: -0.1530 S22: 0.0082 S23: 0.3142 REMARK 3 S31: 0.0126 S32: -0.1933 S33: 0.0080 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D -2 D 208 REMARK 3 ORIGIN FOR THE GROUP (A): -4.4243 -19.3222 67.7741 REMARK 3 T TENSOR REMARK 3 T11: -0.1366 T22: -0.1899 REMARK 3 T33: -0.1913 T12: -0.0157 REMARK 3 T13: 0.0024 T23: -0.0154 REMARK 3 L TENSOR REMARK 3 L11: 1.4582 L22: 1.3732 REMARK 3 L33: 1.5349 L12: 0.2713 REMARK 3 L13: 0.3888 L23: 0.2998 REMARK 3 S TENSOR REMARK 3 S11: 0.0287 S12: 0.1249 S13: -0.1230 REMARK 3 S21: -0.1182 S22: 0.0206 S23: 0.0483 REMARK 3 S31: 0.1806 S32: -0.0301 S33: -0.0493 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E -8 E 207 REMARK 3 ORIGIN FOR THE GROUP (A): 21.9007 -14.1810 62.3281 REMARK 3 T TENSOR REMARK 3 T11: -0.1618 T22: -0.1709 REMARK 3 T33: -0.1712 T12: 0.0272 REMARK 3 T13: 0.0082 T23: -0.0180 REMARK 3 L TENSOR REMARK 3 L11: 1.1421 L22: 1.1691 REMARK 3 L33: 1.4435 L12: 0.1419 REMARK 3 L13: -0.4408 L23: -0.3763 REMARK 3 S TENSOR REMARK 3 S11: -0.0689 S12: 0.0986 S13: -0.0517 REMARK 3 S21: -0.1331 S22: -0.0079 S23: -0.1169 REMARK 3 S31: 0.1249 S32: 0.0084 S33: 0.0768 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. GLOBAL B-FACTORS, CONTAINING RESIDUAL AND TLS REMARK 3 COMPONENT HAVE BEEN DEPOSITED REMARK 4 REMARK 4 2WNJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1290040364. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.885600 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 122269 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 47.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2BYN REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 13% PEG4000, 0.1 M HEPES PH 7.5, 15% REMARK 280 ISOPROPANOL, 15% GLYCEROL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.61100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.64200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 57.39950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.64200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.61100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 57.39950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 44440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -51.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -8 REMARK 465 TYR A -7 REMARK 465 LYS A -6 REMARK 465 ASP A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 LYS A -1 REMARK 465 ALA A 209 REMARK 465 GLY A 210 REMARK 465 ASN A 211 REMARK 465 GLY A 212 REMARK 465 PHE A 213 REMARK 465 PHE A 214 REMARK 465 ARG A 215 REMARK 465 ASN A 216 REMARK 465 LEU A 217 REMARK 465 PHE A 218 REMARK 465 ASP A 219 REMARK 465 ASP B -8 REMARK 465 TYR B -7 REMARK 465 LYS B -6 REMARK 465 ASP B -5 REMARK 465 ASP B -4 REMARK 465 ALA B 209 REMARK 465 GLY B 210 REMARK 465 ASN B 211 REMARK 465 GLY B 212 REMARK 465 PHE B 213 REMARK 465 PHE B 214 REMARK 465 ARG B 215 REMARK 465 ASN B 216 REMARK 465 LEU B 217 REMARK 465 PHE B 218 REMARK 465 ASP B 219 REMARK 465 ASP C -8 REMARK 465 TYR C -7 REMARK 465 ARG C 208 REMARK 465 ALA C 209 REMARK 465 GLY C 210 REMARK 465 ASN C 211 REMARK 465 GLY C 212 REMARK 465 PHE C 213 REMARK 465 PHE C 214 REMARK 465 ARG C 215 REMARK 465 ASN C 216 REMARK 465 LEU C 217 REMARK 465 PHE C 218 REMARK 465 ASP C 219 REMARK 465 ASP D -8 REMARK 465 TYR D -7 REMARK 465 LYS D -6 REMARK 465 ASP D -5 REMARK 465 ASP D -4 REMARK 465 ASP D -3 REMARK 465 ALA D 209 REMARK 465 GLY D 210 REMARK 465 ASN D 211 REMARK 465 GLY D 212 REMARK 465 PHE D 213 REMARK 465 PHE D 214 REMARK 465 ARG D 215 REMARK 465 ASN D 216 REMARK 465 LEU D 217 REMARK 465 PHE D 218 REMARK 465 ASP D 219 REMARK 465 ALA E 209 REMARK 465 GLY E 210 REMARK 465 ASN E 211 REMARK 465 GLY E 212 REMARK 465 PHE E 213 REMARK 465 PHE E 214 REMARK 465 ARG E 215 REMARK 465 ASN E 216 REMARK 465 LEU E 217 REMARK 465 PHE E 218 REMARK 465 ASP E 219 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 2128 O HOH B 2130 2.01 REMARK 500 OD2 ASP D 159 O HOH D 2146 2.08 REMARK 500 O HOH C 2136 O HOH C 2142 2.09 REMARK 500 ND2 ASN B 74 O5 NAG B 401 2.11 REMARK 500 OG1 THR A 160 O HOH A 2168 2.11 REMARK 500 OE1 GLN E 105 O HOH E 2127 2.12 REMARK 500 NZ LYS A 157 O HOH A 2163 2.12 REMARK 500 O HOH E 2074 O HOH E 2103 2.14 REMARK 500 O HOH E 2010 O HOH E 2011 2.16 REMARK 500 NH2 ARG B 59 OD2 ASP B 159 2.18 REMARK 500 O HOH C 2066 O HOH C 2165 2.19 REMARK 500 O HOH C 2104 O HOH C 2105 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 59 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG C 59 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 14 -67.96 -98.35 REMARK 500 ASN A 15 -3.96 -59.65 REMARK 500 ARG A 16 -71.56 -131.15 REMARK 500 PRO A 18 157.78 -48.17 REMARK 500 ASP A 133 30.38 -95.64 REMARK 500 SER B 94 34.24 -140.41 REMARK 500 ASP B 133 30.45 -91.23 REMARK 500 SER C 94 37.66 -142.87 REMARK 500 PHE D 14 -60.92 -106.15 REMARK 500 SER E 94 36.35 -144.25 REMARK 500 ASP E 133 47.64 -91.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2010 DISTANCE = 6.76 ANGSTROMS REMARK 525 HOH E2048 DISTANCE = 6.99 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WN9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF APLYSIA ACHBP IN COMPLEX WITH 4-0H-DMXBA REMARK 900 RELATED ID: 2W8F RELATED DB: PDB REMARK 900 APLYSIA CALIFORNICA ACHBP BOUND TO IN SILICO COMPOUND 31 REMARK 900 RELATED ID: 2BR8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACETYLCHOLINE-BINDING PROTEIN (ACHBP) FROM REMARK 900 APLYSIA CALIFORNICA IN COMPLEX WITH AN ALPHA-CONOTOXIN PNIA VARIANT REMARK 900 RELATED ID: 2BR7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACETYLCHOLINE-BINDING PROTEIN (ACHBP) FROM REMARK 900 APLYSIA CALIFORNICA IN COMPLEX WITH HEPES REMARK 900 RELATED ID: 2BYR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACHBP FROM APLYSIA CALIFORNICA IN COMPLEX WITH REMARK 900 METHYLLYCACONITINE REMARK 900 RELATED ID: 2BYP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF APLYSIA CALIFORNICA ACHBP IN COMPLEX WITH REMARK 900 ALPHA-CONOTOXIN IMI REMARK 900 RELATED ID: 2BYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACHBP FROM APLYSIA CALIFORNICA IN COMPLEX WITH REMARK 900 LOBELINE REMARK 900 RELATED ID: 2BYN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF APO ACHBP FROM APLYSIA CALIFORNICA REMARK 900 RELATED ID: 2C9T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) FROM REMARK 900 APLYSIA CALIFORNICA IN COMPLEX WITH ALPHA-CONOTOXIN IMI REMARK 900 RELATED ID: 2W8E RELATED DB: PDB REMARK 900 APLYSIA CALIFORNICA ACHBP IN APO STATE REMARK 900 RELATED ID: 2BYQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF APLYSIA CALIFORNICA ACHBP IN COMPLEX WITH REMARK 900 EPIBATIDINE REMARK 900 RELATED ID: 2W8G RELATED DB: PDB REMARK 900 APLYSIA CALIFORNICA ACHBP BOUND TO IN SILICO COMPOUND 35 REMARK 900 RELATED ID: 2WNC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF APLYSIA ACHBP IN COMPLEX WITH TROPISETRON REMARK 900 RELATED ID: 2UZ6 RELATED DB: PDB REMARK 900 ACHBP-TARGETED A-CONOTOXIN CORRELATES DISTINCT BINDING ORIENTATIONS REMARK 900 WITH NACHR SUBTYPE SELECTIVITY. REMARK 900 RELATED ID: 2WNL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF APLYSIA ACHBP IN COMPLEX WITH ANABASEINE DBREF 2WNJ A -8 0 PDB 2WNJ 2WNJ -8 0 DBREF 2WNJ A 1 219 UNP Q8WSF8 Q8WSF8_APLCA 18 236 DBREF 2WNJ B -8 0 PDB 2WNJ 2WNJ -8 0 DBREF 2WNJ B 1 219 UNP Q8WSF8 Q8WSF8_APLCA 18 236 DBREF 2WNJ C -8 0 PDB 2WNJ 2WNJ -8 0 DBREF 2WNJ C 1 219 UNP Q8WSF8 Q8WSF8_APLCA 18 236 DBREF 2WNJ D -8 0 PDB 2WNJ 2WNJ -8 0 DBREF 2WNJ D 1 219 UNP Q8WSF8 Q8WSF8_APLCA 18 236 DBREF 2WNJ E -8 0 PDB 2WNJ 2WNJ -8 0 DBREF 2WNJ E 1 219 UNP Q8WSF8 Q8WSF8_APLCA 18 236 SEQRES 1 A 228 ASP TYR LYS ASP ASP ASP ASP LYS LEU HIS SER GLN ALA SEQRES 2 A 228 ASN LEU MET ARG LEU LYS SER ASP LEU PHE ASN ARG SER SEQRES 3 A 228 PRO MET TYR PRO GLY PRO THR LYS ASP ASP PRO LEU THR SEQRES 4 A 228 VAL THR LEU GLY PHE THR LEU GLN ASP ILE VAL LYS ALA SEQRES 5 A 228 ASP SER SER THR ASN GLU VAL ASP LEU VAL TYR TYR GLU SEQRES 6 A 228 GLN GLN ARG TRP LYS LEU ASN SER LEU MET TRP ASP PRO SEQRES 7 A 228 ASN GLU TYR GLY ASN ILE THR ASP PHE ARG THR SER ALA SEQRES 8 A 228 ALA ASP ILE TRP THR PRO ASP ILE THR ALA TYR SER SER SEQRES 9 A 228 THR ARG PRO VAL GLN VAL LEU SER PRO GLN ILE ALA VAL SEQRES 10 A 228 VAL THR HIS ASP GLY SER VAL MET PHE ILE PRO ALA GLN SEQRES 11 A 228 ARG LEU SER PHE MET CYS ASP PRO THR GLY VAL ASP SER SEQRES 12 A 228 GLU GLU GLY ALA THR CYS ALA VAL LYS PHE GLY SER TRP SEQRES 13 A 228 VAL TYR SER GLY PHE GLU ILE ASP LEU LYS THR ASP THR SEQRES 14 A 228 ASP GLN VAL ASP LEU SER SER TYR TYR ALA SER SER LYS SEQRES 15 A 228 TYR GLU ILE LEU SER ALA THR GLN THR ARG GLN VAL GLN SEQRES 16 A 228 HIS TYR SER CYS CYS PRO GLU PRO TYR ILE ASP VAL ASN SEQRES 17 A 228 LEU VAL VAL LYS PHE ARG GLU ARG ARG ALA GLY ASN GLY SEQRES 18 A 228 PHE PHE ARG ASN LEU PHE ASP SEQRES 1 B 228 ASP TYR LYS ASP ASP ASP ASP LYS LEU HIS SER GLN ALA SEQRES 2 B 228 ASN LEU MET ARG LEU LYS SER ASP LEU PHE ASN ARG SER SEQRES 3 B 228 PRO MET TYR PRO GLY PRO THR LYS ASP ASP PRO LEU THR SEQRES 4 B 228 VAL THR LEU GLY PHE THR LEU GLN ASP ILE VAL LYS ALA SEQRES 5 B 228 ASP SER SER THR ASN GLU VAL ASP LEU VAL TYR TYR GLU SEQRES 6 B 228 GLN GLN ARG TRP LYS LEU ASN SER LEU MET TRP ASP PRO SEQRES 7 B 228 ASN GLU TYR GLY ASN ILE THR ASP PHE ARG THR SER ALA SEQRES 8 B 228 ALA ASP ILE TRP THR PRO ASP ILE THR ALA TYR SER SER SEQRES 9 B 228 THR ARG PRO VAL GLN VAL LEU SER PRO GLN ILE ALA VAL SEQRES 10 B 228 VAL THR HIS ASP GLY SER VAL MET PHE ILE PRO ALA GLN SEQRES 11 B 228 ARG LEU SER PHE MET CYS ASP PRO THR GLY VAL ASP SER SEQRES 12 B 228 GLU GLU GLY ALA THR CYS ALA VAL LYS PHE GLY SER TRP SEQRES 13 B 228 VAL TYR SER GLY PHE GLU ILE ASP LEU LYS THR ASP THR SEQRES 14 B 228 ASP GLN VAL ASP LEU SER SER TYR TYR ALA SER SER LYS SEQRES 15 B 228 TYR GLU ILE LEU SER ALA THR GLN THR ARG GLN VAL GLN SEQRES 16 B 228 HIS TYR SER CYS CYS PRO GLU PRO TYR ILE ASP VAL ASN SEQRES 17 B 228 LEU VAL VAL LYS PHE ARG GLU ARG ARG ALA GLY ASN GLY SEQRES 18 B 228 PHE PHE ARG ASN LEU PHE ASP SEQRES 1 C 228 ASP TYR LYS ASP ASP ASP ASP LYS LEU HIS SER GLN ALA SEQRES 2 C 228 ASN LEU MET ARG LEU LYS SER ASP LEU PHE ASN ARG SER SEQRES 3 C 228 PRO MET TYR PRO GLY PRO THR LYS ASP ASP PRO LEU THR SEQRES 4 C 228 VAL THR LEU GLY PHE THR LEU GLN ASP ILE VAL LYS ALA SEQRES 5 C 228 ASP SER SER THR ASN GLU VAL ASP LEU VAL TYR TYR GLU SEQRES 6 C 228 GLN GLN ARG TRP LYS LEU ASN SER LEU MET TRP ASP PRO SEQRES 7 C 228 ASN GLU TYR GLY ASN ILE THR ASP PHE ARG THR SER ALA SEQRES 8 C 228 ALA ASP ILE TRP THR PRO ASP ILE THR ALA TYR SER SER SEQRES 9 C 228 THR ARG PRO VAL GLN VAL LEU SER PRO GLN ILE ALA VAL SEQRES 10 C 228 VAL THR HIS ASP GLY SER VAL MET PHE ILE PRO ALA GLN SEQRES 11 C 228 ARG LEU SER PHE MET CYS ASP PRO THR GLY VAL ASP SER SEQRES 12 C 228 GLU GLU GLY ALA THR CYS ALA VAL LYS PHE GLY SER TRP SEQRES 13 C 228 VAL TYR SER GLY PHE GLU ILE ASP LEU LYS THR ASP THR SEQRES 14 C 228 ASP GLN VAL ASP LEU SER SER TYR TYR ALA SER SER LYS SEQRES 15 C 228 TYR GLU ILE LEU SER ALA THR GLN THR ARG GLN VAL GLN SEQRES 16 C 228 HIS TYR SER CYS CYS PRO GLU PRO TYR ILE ASP VAL ASN SEQRES 17 C 228 LEU VAL VAL LYS PHE ARG GLU ARG ARG ALA GLY ASN GLY SEQRES 18 C 228 PHE PHE ARG ASN LEU PHE ASP SEQRES 1 D 228 ASP TYR LYS ASP ASP ASP ASP LYS LEU HIS SER GLN ALA SEQRES 2 D 228 ASN LEU MET ARG LEU LYS SER ASP LEU PHE ASN ARG SER SEQRES 3 D 228 PRO MET TYR PRO GLY PRO THR LYS ASP ASP PRO LEU THR SEQRES 4 D 228 VAL THR LEU GLY PHE THR LEU GLN ASP ILE VAL LYS ALA SEQRES 5 D 228 ASP SER SER THR ASN GLU VAL ASP LEU VAL TYR TYR GLU SEQRES 6 D 228 GLN GLN ARG TRP LYS LEU ASN SER LEU MET TRP ASP PRO SEQRES 7 D 228 ASN GLU TYR GLY ASN ILE THR ASP PHE ARG THR SER ALA SEQRES 8 D 228 ALA ASP ILE TRP THR PRO ASP ILE THR ALA TYR SER SER SEQRES 9 D 228 THR ARG PRO VAL GLN VAL LEU SER PRO GLN ILE ALA VAL SEQRES 10 D 228 VAL THR HIS ASP GLY SER VAL MET PHE ILE PRO ALA GLN SEQRES 11 D 228 ARG LEU SER PHE MET CYS ASP PRO THR GLY VAL ASP SER SEQRES 12 D 228 GLU GLU GLY ALA THR CYS ALA VAL LYS PHE GLY SER TRP SEQRES 13 D 228 VAL TYR SER GLY PHE GLU ILE ASP LEU LYS THR ASP THR SEQRES 14 D 228 ASP GLN VAL ASP LEU SER SER TYR TYR ALA SER SER LYS SEQRES 15 D 228 TYR GLU ILE LEU SER ALA THR GLN THR ARG GLN VAL GLN SEQRES 16 D 228 HIS TYR SER CYS CYS PRO GLU PRO TYR ILE ASP VAL ASN SEQRES 17 D 228 LEU VAL VAL LYS PHE ARG GLU ARG ARG ALA GLY ASN GLY SEQRES 18 D 228 PHE PHE ARG ASN LEU PHE ASP SEQRES 1 E 228 ASP TYR LYS ASP ASP ASP ASP LYS LEU HIS SER GLN ALA SEQRES 2 E 228 ASN LEU MET ARG LEU LYS SER ASP LEU PHE ASN ARG SER SEQRES 3 E 228 PRO MET TYR PRO GLY PRO THR LYS ASP ASP PRO LEU THR SEQRES 4 E 228 VAL THR LEU GLY PHE THR LEU GLN ASP ILE VAL LYS ALA SEQRES 5 E 228 ASP SER SER THR ASN GLU VAL ASP LEU VAL TYR TYR GLU SEQRES 6 E 228 GLN GLN ARG TRP LYS LEU ASN SER LEU MET TRP ASP PRO SEQRES 7 E 228 ASN GLU TYR GLY ASN ILE THR ASP PHE ARG THR SER ALA SEQRES 8 E 228 ALA ASP ILE TRP THR PRO ASP ILE THR ALA TYR SER SER SEQRES 9 E 228 THR ARG PRO VAL GLN VAL LEU SER PRO GLN ILE ALA VAL SEQRES 10 E 228 VAL THR HIS ASP GLY SER VAL MET PHE ILE PRO ALA GLN SEQRES 11 E 228 ARG LEU SER PHE MET CYS ASP PRO THR GLY VAL ASP SER SEQRES 12 E 228 GLU GLU GLY ALA THR CYS ALA VAL LYS PHE GLY SER TRP SEQRES 13 E 228 VAL TYR SER GLY PHE GLU ILE ASP LEU LYS THR ASP THR SEQRES 14 E 228 ASP GLN VAL ASP LEU SER SER TYR TYR ALA SER SER LYS SEQRES 15 E 228 TYR GLU ILE LEU SER ALA THR GLN THR ARG GLN VAL GLN SEQRES 16 E 228 HIS TYR SER CYS CYS PRO GLU PRO TYR ILE ASP VAL ASN SEQRES 17 E 228 LEU VAL VAL LYS PHE ARG GLU ARG ARG ALA GLY ASN GLY SEQRES 18 E 228 PHE PHE ARG ASN LEU PHE ASP MODRES 2WNJ ASN A 74 ASN GLYCOSYLATION SITE MODRES 2WNJ ASN B 74 ASN GLYCOSYLATION SITE HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET MAN F 4 11 HET ZY7 A 301 46 HET ZY7 B 301 23 HET NAG B 401 14 HET ZY7 C 301 23 HET ZY7 D 301 46 HET ZY7 E 301 46 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM ZY7 (3E)-3-[(2,4-DIMETHOXYPHENYL)METHYLIDENE]-3,4,5,6- HETNAM 2 ZY7 TETRAHYDRO-2,3'-BIPYRIDINE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 6 NAG 3(C8 H15 N O6) FORMUL 6 BMA C6 H12 O6 FORMUL 6 MAN C6 H12 O6 FORMUL 7 ZY7 5(C19 H20 N2 O2) FORMUL 13 HOH *992(H2 O) HELIX 1 1 LEU A 0 PHE A 14 1 15 HELIX 2 2 LEU A 62 MET A 66 5 5 HELIX 3 3 ASP A 68 TYR A 72 5 5 HELIX 4 4 ALA A 83 ILE A 85 5 3 HELIX 5 5 ASP B -3 ASN B 15 1 19 HELIX 6 6 LEU B 62 MET B 66 5 5 HELIX 7 7 ASP B 68 TYR B 72 5 5 HELIX 8 8 ALA B 83 ILE B 85 5 3 HELIX 9 9 LYS C -6 ASN C 15 1 22 HELIX 10 10 LEU C 62 MET C 66 5 5 HELIX 11 11 ASP C 68 TYR C 72 5 5 HELIX 12 12 ALA C 83 ILE C 85 5 3 HELIX 13 13 ASP D -2 PHE D 14 1 17 HELIX 14 14 LEU D 62 MET D 66 5 5 HELIX 15 15 ASP D 68 TYR D 72 5 5 HELIX 16 16 ALA D 83 ILE D 85 5 3 HELIX 17 17 ASP E -8 ASN E 15 1 24 HELIX 18 18 LEU E 62 MET E 66 5 5 HELIX 19 19 ASP E 68 TYR E 72 5 5 HELIX 20 20 ALA E 83 ILE E 85 5 3 SHEET 1 AA 2 LEU A 29 THR A 32 0 SHEET 2 AA 2 ILE A 154 LYS A 157 1 O ASP A 155 N VAL A 31 SHEET 1 AB 4 THR A 36 ASP A 44 0 SHEET 2 AB 4 GLU A 49 TYR A 55 -1 O GLU A 49 N ASP A 44 SHEET 3 AB 4 ALA A 120 MET A 126 -1 O GLN A 121 N TYR A 54 SHEET 4 AB 4 GLN A 100 VAL A 101 -1 O GLN A 100 N ARG A 122 SHEET 1 AC 4 GLN A 58 TRP A 60 0 SHEET 2 AC 4 VAL A 115 PHE A 117 -1 O VAL A 115 N TRP A 60 SHEET 3 AC 4 ILE A 106 THR A 110 -1 O VAL A 108 N MET A 116 SHEET 4 AC 4 ASP A 77 SER A 81 -1 O PHE A 78 N VAL A 109 SHEET 1 AD 3 THR A 139 PHE A 144 0 SHEET 2 AD 3 TYR A 195 GLU A 206 -1 O VAL A 198 N PHE A 144 SHEET 3 AD 3 TYR A 174 GLN A 186 -1 O GLU A 175 N ARG A 205 SHEET 1 BA 2 LEU B 29 THR B 32 0 SHEET 2 BA 2 ILE B 154 LYS B 157 1 O ASP B 155 N VAL B 31 SHEET 1 BB 4 THR B 36 ASP B 44 0 SHEET 2 BB 4 GLU B 49 TYR B 55 -1 O GLU B 49 N ASP B 44 SHEET 3 BB 4 ALA B 120 MET B 126 -1 O GLN B 121 N TYR B 54 SHEET 4 BB 4 GLN B 100 VAL B 101 -1 O GLN B 100 N ARG B 122 SHEET 1 BC 4 GLN B 58 TRP B 60 0 SHEET 2 BC 4 VAL B 115 PHE B 117 -1 O VAL B 115 N TRP B 60 SHEET 3 BC 4 ILE B 106 THR B 110 -1 O VAL B 108 N MET B 116 SHEET 4 BC 4 ASP B 77 SER B 81 -1 O PHE B 78 N VAL B 109 SHEET 1 BD 3 THR B 139 PHE B 144 0 SHEET 2 BD 3 TYR B 195 GLU B 206 -1 O VAL B 198 N PHE B 144 SHEET 3 BD 3 TYR B 174 GLN B 186 -1 O GLU B 175 N ARG B 205 SHEET 1 CA 2 LEU C 29 THR C 32 0 SHEET 2 CA 2 ILE C 154 LYS C 157 1 O ASP C 155 N VAL C 31 SHEET 1 CB 4 THR C 36 ASP C 44 0 SHEET 2 CB 4 GLU C 49 TYR C 55 -1 O GLU C 49 N ASP C 44 SHEET 3 CB 4 ALA C 120 MET C 126 -1 O GLN C 121 N TYR C 54 SHEET 4 CB 4 GLN C 100 VAL C 101 -1 O GLN C 100 N ARG C 122 SHEET 1 CC 4 GLN C 58 TRP C 60 0 SHEET 2 CC 4 VAL C 115 PHE C 117 -1 O VAL C 115 N TRP C 60 SHEET 3 CC 4 ILE C 106 THR C 110 -1 O VAL C 108 N MET C 116 SHEET 4 CC 4 ASP C 77 SER C 81 -1 O PHE C 78 N VAL C 109 SHEET 1 CD 3 THR C 139 PHE C 144 0 SHEET 2 CD 3 TYR C 195 GLU C 206 -1 O VAL C 198 N PHE C 144 SHEET 3 CD 3 TYR C 174 GLN C 186 -1 O GLU C 175 N ARG C 205 SHEET 1 DA 2 LEU D 29 THR D 32 0 SHEET 2 DA 2 ILE D 154 LYS D 157 1 O ASP D 155 N VAL D 31 SHEET 1 DB 4 THR D 36 ASP D 44 0 SHEET 2 DB 4 GLU D 49 TYR D 55 -1 O GLU D 49 N ASP D 44 SHEET 3 DB 4 ALA D 120 MET D 126 -1 O GLN D 121 N TYR D 54 SHEET 4 DB 4 GLN D 100 VAL D 101 -1 O GLN D 100 N ARG D 122 SHEET 1 DC 4 GLN D 58 TRP D 60 0 SHEET 2 DC 4 VAL D 115 PHE D 117 -1 O VAL D 115 N TRP D 60 SHEET 3 DC 4 ILE D 106 THR D 110 -1 O VAL D 108 N MET D 116 SHEET 4 DC 4 ASP D 77 SER D 81 -1 O PHE D 78 N VAL D 109 SHEET 1 DD 3 THR D 139 PHE D 144 0 SHEET 2 DD 3 TYR D 195 GLU D 206 -1 O VAL D 198 N PHE D 144 SHEET 3 DD 3 TYR D 174 GLN D 186 -1 O GLU D 175 N ARG D 205 SHEET 1 EA 2 LEU E 29 THR E 32 0 SHEET 2 EA 2 ILE E 154 LYS E 157 1 O ASP E 155 N VAL E 31 SHEET 1 EB 4 THR E 36 ASP E 44 0 SHEET 2 EB 4 GLU E 49 TYR E 55 -1 O GLU E 49 N ASP E 44 SHEET 3 EB 4 ALA E 120 MET E 126 -1 O GLN E 121 N TYR E 54 SHEET 4 EB 4 GLN E 100 VAL E 101 -1 O GLN E 100 N ARG E 122 SHEET 1 EC 4 GLN E 58 TRP E 60 0 SHEET 2 EC 4 VAL E 115 PHE E 117 -1 O VAL E 115 N TRP E 60 SHEET 3 EC 4 ILE E 106 THR E 110 -1 O VAL E 108 N MET E 116 SHEET 4 EC 4 ASP E 77 SER E 81 -1 O PHE E 78 N VAL E 109 SHEET 1 ED 3 THR E 139 PHE E 144 0 SHEET 2 ED 3 TYR E 195 GLU E 206 -1 O VAL E 198 N PHE E 144 SHEET 3 ED 3 TYR E 174 GLN E 186 -1 O GLU E 175 N ARG E 205 SSBOND 1 CYS A 127 CYS A 140 1555 1555 1.97 SSBOND 2 CYS A 190 CYS A 191 1555 1555 2.04 SSBOND 3 CYS B 127 CYS B 140 1555 1555 1.94 SSBOND 4 CYS B 190 CYS B 191 1555 1555 2.05 SSBOND 5 CYS C 127 CYS C 140 1555 1555 1.92 SSBOND 6 CYS C 190 CYS C 191 1555 1555 2.03 SSBOND 7 CYS D 127 CYS D 140 1555 1555 1.98 SSBOND 8 CYS D 190 CYS D 191 1555 1555 2.05 SSBOND 9 CYS E 127 CYS E 140 1555 1555 1.93 SSBOND 10 CYS E 190 CYS E 191 1555 1555 2.07 LINK ND2 ASN A 74 C1 NAG F 1 1555 1555 1.40 LINK ND2 ASN B 74 C1 NAG B 401 1555 1555 1.40 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.43 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.42 LINK O3 BMA F 3 C1 MAN F 4 1555 1555 1.42 CRYST1 87.222 114.799 131.284 90.00 90.00 90.00 P 21 21 21 20 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011465 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008711 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007617 0.00000